Efficacy and Safety Study of Probucol in Patients With Diabetic Nephropathy

Summary

This trial is randomized, placebo-controlled, double blind, double dummy, multi-centre trial. * Screening period (4 week) * Double blind treatment period (16 weeks)

Timeline

Start

2012-10

Primary completion

2014-04

Completion

2014-09

Publications

• Jin SM, Han KA, Yu JM, Sohn TS, Choi SH, Chung CH, Park IeB, Rhee EJ, Baik SH, Park TS, Lee IK, Ko SH, Hwang YC, Cha BS, Lee HW, Nam MS, Lee MK. Probucol in Albuminuric Type 2 Diabetes Mellitus Patients on Renin-Angiotensin System Blockade: A 16-Week, Randomized, Double-Blind, Placebo-Controlled Trial. Arterioscler Thromb Vasc Biol. 2016 Oct;36(10):2108-14. doi: 10.1161/ATVBAHA.116.308034. Epub 2016 Aug 4.

Drugs

Indications